New book by Larry Connors Click here Improve your trading - See how
Particle Drilling Technologies Inc. (NASDAQ: PDRT | Quote | Chart | News | PowerRating) a development stage company, engages in the development of a proprietary drilling system for oil and gas industry in the United States. The company's technology is designed to increase the rate-of-penetration in the drilling process, primarily in hard rock drilling environments. Its system is designed to entrain, circulate, and recover the particles in the mud system without allowing the particles to circulate through the rig pumps. The company was founded in 2002 and is based in Houston, Texas. With 35.76 million shares outstanding and 93,900 shares declared short as of September 2008, there is no longer a failure to deliver in shares of PDRT. According to quarterly data provided by the SEC, there were still 887,248 shares of PDRT that were failing-to-deliver as of February 28, 2008.
Summer Infant Inc. (NASDAQ: SUMR | Quote | Chart | News | PowerRating) designs, markets, and distributes branded juvenile health, safety, and wellness products to retailer primarily in North America, the United Kingdom, and other parts of Europe. It offers products in various categories, including nursery audio/video monitors, safety gates, durable bath products, bed rails, infant thermometers, related health and safety products, booster and potty seats, and bouncers, as well as a line of soft goods/bedding. The company offers its products through various distribution channels, including chain retailers, specialty retailers, and direct to consumers. Summer Infant, Inc. is headquartered in Woonsocket, Rhode Island. With 15.06 million shares outstanding and 154,600 shares declared short as of September 2008, there is no longer a failure to deliver in shares of SUMR. According to quarterly data provided by the SEC, there were still 263,744 shares of SUMR that were failing-to-deliver as of June 30, 2008.
VIA Pharmaceuticals Inc. (NASDAQ: VIAP | Quote | Chart | News | PowerRating) a development stage biotechnology company, focuses on the research and development of compounds for the treatment cardiovascular diseases. The company is building a pipeline of small-molecule drugs that target inflammation in the blood vessel wall, an underlying cause of atherosclerosis and its complications, including heart attack and stroke. Its principal product, VIA-2291, is in two concurrent Phase II clinical studies in patients with acute coronary syndrome and patients with stenosis of the carotid artery. VIA Pharmaceuticals was founded in 2004 and is headquartered in San Francisco, California. With 19.73 million shares outstanding and 15,200 shares declared short as of September 2008, there is no longer a failure to deliver in shares of VIAP. According to quarterly data provided by the SEC, there were still 117,378 shares of VIAP that were failing-to-deliver as of November 16, 2007.
Access Pharmaceuticals Inc. (OTCBB: ACCP | Quote | Chart | News | PowerRating) a biopharmaceutical company, together with its subsidiaries, engages in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients. The company's products include MuGard, a nanopolymer formulation for the management of oral mucositis, a frequent side-effect of cancer therapy. Its lead development candidate for the treatment of cancer includes ProLindac, a Phase II clinical trial candidate for the treatment of ovarian cancer. The company's products under pre-clinical stage comprise Cobalamin, an oral drug delivery technology for the oral delivery of insulin; and Angiolix, a humanized monoclonal antibody, which acts as an anti-angiogenesis factor to cancer cells, notably breast, ovarian, and colorectal cancers. Its products under pre-clinical stage also comprise Prodrax, a non-toxic prodrug that is activated in the hypoxic zones of solid tumors to kill cancer cells; Alchemix, a chemotherapeutic agent, which combines multiple modes of action to overcome drug resistance; and Cobalamin-mediated targeted delivery. The company has a co-development and sublicense agreement with Virium Pharmaceuticals, Inc. to develop Sodium Phenylbutyrate, a Phase II clinical candidate for the treatment of cancer, autoimmune diseases, and other clinical indications; and a research collaboration with The School of Pharmacy, University of London to develop a synthetic polymer technology to exploit enhanced permeability and retention at tumor sites to accumulate drug and control drug release. Access Pharmaceuticals, Inc. was founded in 1988 and is based in Dallas, Texas. With 17.31 million shares outstanding and 140,500 shares declared short as of September 2008, there is no longer a failure to deliver in shares of ACCP. According to quarterly data provided by the SEC, there were still 37,631 shares of ACCP that were failing-to-deliver as of March 9, 2007.
Pop N Go, Inc. (OTCBB: POPN | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the manufacture and development of coin-operated popcorn machines principally in the United States. It principal product includes Pop N Go, a hot air-based popcorn vending machine. These machines are located in shopping centers, schools, convenience stores, supermarkets, bowling alleys, car washes, and military bases, as well as in a range of other retail, industrial, and office locations. The company sells its machines to distributors and retail establishments. It also sells its products in Mexico, Canada, China, Cyprus, Korea, Lebanon, Venezuela, Australia, and Israel. The company was founded in 1996 and is based in Whittier, California. With 462.11 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of POPN. According to quarterly data provided by the SEC, there were still 19,441,527 shares of POPN that were failing-to-deliver as of May 13, 2008.
Gigabeam Corp. (OTC: GGBM | Quote | Chart | News | PowerRating) through its subsidiary, GigaBeam Service Corporation, engages in the design, development, marketing, sale, lease, installation, and service of advanced point-to-point wireless communication solutions for commercial and government customers in the United States. It offers WiFiber G series GigE, which is designed to operate at approximately 1.25 gigabits-per-second speed. The company's wireless communications solution is a point-to-point, line of sight, wireless high-speed communications link, established between two GigaBeam transceiver units that are linked wirelessly through the alignment of their antennas and their transmission of data via radio signals in the 71-76 GHz and 81-86 GHz spectrum bands. It serves telecom operators; carriers and network operators; communications and IT service providers, including wireless local exchange carriers, system integrators, and value added resellers; government agencies; and financial services organizations. GigaBeam Corporation has strategic alliances with ThinKom Solutions, Inc.; Mantaro Networks, Inc.; Vitesse Semiconductor Corporation; and Core Source, LLC. The company was founded in 2004 and is headquartered in Durham, North Carolina. With 7.14 million shares outstanding and 216,500 shares declared short as of September 2008, there is no longer a failure to deliver in shares of GGBM. According to quarterly data provided by the SEC, there were still 337,441 shares of GGBM that were failing-to-deliver as of August 3, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,200,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
